Cormorant Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Cormorant Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-459,000	Closed	-$29.6M	–	81
2015 Q1	$29.6M	Buy	459,000 +209,000	+84%	+$13.1M	4.58%	5
2014 Q4	$14.8M	Buy	250,000 +100,000	+67%	+$5.64M	2.28%	14
2014 Q3	$7.68M	Buy	+150,000	New	+$7.49M	1.58%	15
2014 Q1	–	Sell	-270,000	Closed	-$14.4M	–	47
2013 Q4	$14.4M	Buy	+270,000	New	+$13.8M	4.16%	11

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cormorant Asset Management's BMY Position: Q2 2015 in Review

Cormorant Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 459,000 shares — an estimated $29.6M sold.

Cormorant Asset Management first reported a position in BMY in Q4 2013 and held it in 4 quarters. The position peaked at $29.6M in Q1 2015. 1,448 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

Cormorant Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
Cormorant Asset Management sold 459,000 Bristol-Myers Squibb shares in Q2 2015, an estimated $29.6M.
Cormorant Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 4 quarters.
Cormorant Asset Management's Bristol-Myers Squibb position peaked at $29.6M in Q1 2015.
1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Cormorant Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.